Leapfrog Engineering Services IPO...
18 Apr, 2026
Rodec Pharma IPO
Rodec Pharma IPO Details
Rodec Pharma Ltd. is a 100% book-built issue of 56.50 lakh equity shares with a face value of ₹10 each. The company filed its DRHP with SEBI on January 11, 2026. The price band and official date of subscription and listing will be announced by the company later, but the shares are intended to be listed on the BSE and the NSE platforms. The book-running lead manager for this issue is Khambatta Securities Ltd., while the registrar to the issue is Bigshare Services Private Ltd.
Rodec Pharma IPO Date & Timeline
Rodec Pharma Ltd. officially filed its Draft Red Herring Prospectus (DRHP) on January 11, 2026. However, the specific Rodec Pharma IPO date and subscription timeline remain unannounced. Following regulatory approval, the company will finalise the price band and bidding dates. Once cleared, the schedule for anchor allotment, public bidding and the final listing on the exchange will be formally disclosed.
Rodec Pharma IPO GMP (Grey Market Premium)
“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.
The Rodec Pharma IPO GMP is currently trading at ₹[.], reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹[.], which is [.]% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
Company Background
Rodec Pharmaceuticals Ltd. was incorporated as a private limited company in 1997. The business was officially renamed Rodec Pharma Private Limited in 2023 before its conversion into a public limited company in 2024. The company has its headquarters in Ghaziabad, Uttar Pradesh and has evolved from a localised business into a recognised veterinary pharmaceutical business. The company’s main business has a high concentration of providing healthcare and nutritional solutions for cattle, effectively integrating its presence in the country from production to distribution.
Operations & Product Range
Rodec Pharma Ltd. is rapidly professionalising the animal health industry. The main business activity is the manufacturing of animal feed supplements as well as the marketing of veterinary pharmaceutical drugs. The company has a wide range of products that cover the basic areas of animal health care that are required to meet the health needs of livestock animals in a strict manner. By meeting the health needs of the animals in this manner, the company is able to target a specific group of clients, such as veterinarians and livestock farmers.
Facilities & Capacity
Rodec Pharma Ltd. securely anchors its operational backbone at its registered corporate location in Meerut Road Industrial Area, Ghaziabad, Uttar Pradesh. The company has a centralized location that serves as the main hub for its manufacturing activities. The company exercises tight quality control over its animal feed supplements to enhance its overall operational capacity without incurring massive capital costs.
Brands & Market Presence
Rodec Pharma Ltd. has managed to create a brand presence within the local veterinary pharmaceutical industry. The company has developed a strong and extensive distribution network within the local market. The company’s distribution network covers a number of significant agricultural states. This allows it to provide veterinary pharmaceuticals to local animal healthcare markets. The company has managed to create a strong presence within the local market, enabling it to deliver much-needed supplies to the local economy.
Revenue Streams & Business Model
Rodec Pharma Ltd. primarily drives its revenue stream through a well-integrated approach that encompasses both production and distribution. There are primarily two key segments of the business: veterinary pharmaceutical drugs and animal feed supplements. The business primarily relies on its distribution network to deliver the products to livestock farmers. By focusing on the delivery of essential animal health care solutions, the business ensures a stable revenue stream linked with the domestic agricultural economy.
Management & Shareholding
Rodec Pharma Ltd. is led by its expert and leading promoters, who are Mukesh Kumar Gupta, Chhaya Gupta and Utkarsh Gupta. In the current issue, the sole promoter's selling shareholder is Mukesh Kumar Gupta. The promoters of the company shall hold a majority of the company's share capital after the issue of the IPO.
Board & Key Management
The overall strategy and operation of Rodec Pharma Ltd. are managed through a well-structured board of directors, led by Mukesh Kumar Gupta, who plays a vital role in the growth and operation of the company. For effective corporate governance, the company has board of directors with experienced directors, who offer unbiased advice. Compliance and secretarial practices are also well managed by CS Keshav Kumar Sharma, who is the Compliance Officer and the company operates under strict regulatory norms.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Rodec Pharma IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Rodec Pharma IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹10 per Equity Share |
| Issue Price Band | - |
| Lot Size | - |
| Sale Type | Offer for Sale (OFS) |
| Total Issue Size | Up to 5,650,000 Equity Shares (Aggregating up to [●] Cr) |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | Not Applicable |
| Offer for Sale | Up to 5,650,000 Equity Shares (Aggregating up to [●] Cr) |
| Net Offered to Public | - |
| Issue Type | 100% Book Built Offer |
| Listing At | BSE and NSE |
| Share Holding Pre Issue | 2,25,84,800 shares |
| Share Holding Post Issue | 2,25,84,800 shares |
Rodec Pharma IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | - |
| IPO Close Date | - |
| Tentative Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Tentative Listing Date | - |
| Cut-off time for UPI mandate confirmation | 5:00 PM on the Bid/Offer Closing Date |
Rodec Pharma IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | - | ~₹14,000 - ₹15,000 |
| Individual investors (Retail) (Max) | 13-14 | - | Up to ₹2,00,000 |
| S-HNI (Min) | 14-15 | - | Over ₹2,00,000 |
| S-HNI (Max) | 66-70 | - | Up to ₹10,00,000 |
| B-HNI (Min) | 71+ | - | Over ₹10,00,000 |
Rodec Pharma IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | 92.40% |
| Promoter Holding Post Issue | - |
Competitive Strength:
- • An integrated business model, which includes the manufacturing and distribution of veterinary products.
- • A diverse and broad range of products, which include critical livestock drugs and feed nutrition.
- • A strong distribution network, which covers major agricultural markets in India.
- • A strong and dedicated management team, which includes experienced promoters who ensure operational efficiency.
Rodec Pharma IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept 30, 2025 | 78.07 | 63.71 | 9.73 | 59.96 | 37.37 | 1.40 | ||||||||||||||||||||||||||||||||||
| Fiscal 2025 | 71.99 | 108.19 | 18.26 | 50.04 | 49.93 | 8.25 | ||||||||||||||||||||||||||||||||||
| Fiscal 2024 | 50.62 | 89.61 | 11.04 | 31.75 | 31.65 | 6.70 | ||||||||||||||||||||||||||||||||||
| Fiscal 2023 | 44.13 | 71.72 | 5.21 | 20.67 | 20.56 | 11.72 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 36.49% |
| ROCE | 40.94% |
| Debt/Equity | 0.17 |
| RoNW | 36.49% |
| PAT Margin | 17.16% |
| EBITDA Margin | 24.21% |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 8.08 | |
| P/E (x) |
Rodec Pharma IPO Objectives
Rodec Pharma Ltd. won’t get any proceeds from this issue, as it is a 100% offer for sale, even though the objectives of this issue are
- • Achieving the benefits of listing equity shares on recognised stock exchanges
- • Enhancing corporate visibility and brand image among existing and potential customers
- • Providing liquidity to the promoter and establishing a public market for the selling shareholder
Rodec Pharma IPO Review
Rodec Pharma Ltd. is a veterinary pharmaceuticals company that deals in animal health products, which will benefit directly from the increased awareness of animal health, particularly in the case of livestock and the increased demand for high-quality animal feed supplements. It already possesses a wide distribution network, which is a major competitive advantage, enabling the company to successfully promote its medicinal products directly to the farmers in the regions.
Since this issue is a 100% OFS structure, there will be no equity dilution in terms of a fresh issue, which will directly influence the existing earnings per share data. It will also enhance its corporate image manifold, but will not influence its capital structure.
However, investors interested must carefully analyse the risks faced by the sector, as this manufacturing company mainly concentrates geographically in Ghaziabad. The Rodec Pharma IPO Review states that the IPO gives investors a chance to invest in the domestic animal health sector, effectively managing the steady demand from rural areas while also considering the risks of relying on a limited supply chain.
Conclusion
The Rodec Pharma IPO is an opportunity for investors to invest in a growing company that has spent decades building a reliable veterinary pharmaceutical brand. By consistently delivering high-quality animal healthcare products. The company has established a highly dependable, recurring revenue model. This issue will help the company in its future success by enhancing the ability to sustain its distribution reach and navigate the competitive landscape of the domestic animal healthcare industry.
IPO DRHP Status
| # | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 11-01-2026 | View DRHP |
| 2 | SEBI/Exchange approval received | - | - |
Learn about IPO fundamentals in our IPO Process guide. Check upcoming IPOs in the IPO Calendar Explore our Corporate Finance Services, SME IPO Consultant, Pre IPO Consultant for IPO guidance.
Read More IPO ReviewsFrequently Asked Questions (FAQs)
-
What are the Rodec Pharma IPO details?
The public offering consists entirely of an Offer for Sale (OFS) of up to 56.50 lakh equity shares with a face value of ₹10 each. It is structured as a 100% book-built issue with no fresh issue component.
-
What does Rodec Pharma do?
The company is an integrated veterinary pharmaceutical entity manufacturing animal feed supplements and marketing veterinary drugs for livestock animals.
-
What are the subscription and listing dates for the Rodec Pharma IPO?
The official date of opening/closing of subscription and listing will be announced by the company later.
-
What is the Rodec Pharma IPO GMP today?
Since the exact issue dates and price band are not yet announced, the GMP is currently unavailable and will be updated when trading begins.
-
What is the total issue size of the Rodec Pharma IPO?
The total size of the IPO is up to 56.50 lakh equity shares, entirely an offer for sale of shares.
-
Who are the promoters of Rodec Pharma?
The promoters are Mukesh Kumar Gupta, Chhaya Gupta and Utkarsh Gupta.
-
Where will the Rodec Pharma IPO be listed?
The equity shares are proposed to be listed on the BSE and the NSE platforms.
